JP2007508247A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007508247A5 JP2007508247A5 JP2006528295A JP2006528295A JP2007508247A5 JP 2007508247 A5 JP2007508247 A5 JP 2007508247A5 JP 2006528295 A JP2006528295 A JP 2006528295A JP 2006528295 A JP2006528295 A JP 2006528295A JP 2007508247 A5 JP2007508247 A5 JP 2007508247A5
- Authority
- JP
- Japan
- Prior art keywords
- bacteria
- nitroso
- composition according
- subject
- autism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Claims (14)
- 高血圧症、肥大性器官退化、レイノー現象、線維性器官退化、アレルギー、自己免疫感作、末期腎不全、肥満、1型糖尿病、骨粗鬆症、インポテンス、脱毛、癌、加齢、自閉症、自閉症の領域の症状、加齢による遅延の少なくとも1つを発症したか、または発症する危険のある対象を処置するための、アンモニア酸化細菌を含む組成物。
- 細菌が、ニトロソモナス、ニトロソコッカス、ニトロソスピラ、ニトロソシスティス、ニトロソロブス、ニトロソビブリオのいずれか、およびそれらの組み合わせからなる群から選択される、請求項1に記載の組成物。
- 細菌を、対象の表面に適用されたときに、該表面上のアンモニア、アンモニウム塩、または尿素のいずれかを、一酸化窒素、一酸化窒素前駆体、またはそれらの組み合わせのいずれかに代謝するのに有効な量で含む、請求項1または2に記載の組成物。
- 細菌が、好適な担体に含まれる、請求項1〜3のいずれかに記載の組成物。
- 皮膚、毛髪、またはそれらの組み合わせに適用される、請求項1〜4のいずれかに記載の組成物。
- 細菌が、実質的に純粋な細菌である、請求項1〜5のいずれかに記載の組成物。
- 物品に適用され、そして該物品を介して対象の表面に適用される、請求項1〜6のいずれかに記載の組成物。
- 細菌が、酸と混合されている、請求項1〜7のいずれかに記載の組成物。
- 動物の成長を増大させる方法であって:
AAOBを該動物の表面から除去すること
を含む、前記方法。 - アンモニア酸化細菌の、一酸化窒素を対象に提供するための医薬の製造における使用であって、前記医薬が、前記対象の表面に適用するのに適しており、ここで、該対象が:高血圧症、肥大性器官退化、レイノー現象、線維性器官退化、アレルギー、自己免疫感作、末期腎不全、肥満、1型糖尿病、骨粗鬆症、インポテンス、脱毛、癌、自閉症、自閉症の領域の症状および加齢による低下した健康の少なくとも1つを発症したか、または発症する危険のある、前記使用。
- 細菌が、ニトロソモナス、ニトロソコッカス、ニトロソスピラ、ニトロソシスティス、ニトロソロブス、ニトロソビブリオのいずれか、およびそれらの組み合わせからなる群から選択される、請求項10に記載の使用。
- 医薬が、細菌が対象の表面上のアンモニア、アンモニウム塩、または尿素のいずれかを、一酸化窒素、一酸化窒素前駆体、またはそれらの組み合わせのいずれかに代謝するのに有効な量で、対象の表面に適用するのに適する、請求項10または11に記載の使用。
- 医薬が、皮膚、毛髪、またはそれらの組み合わせに適用するのに適する、請求項10〜12のいずれかに記載の使用。
- 医薬が、物品に適用するのに適し、物品が、対象の表面と接触するのに適する、請求項10〜13のいずれかに記載の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50622503P | 2003-09-26 | 2003-09-26 | |
US58565204P | 2004-07-06 | 2004-07-06 | |
PCT/US2004/031690 WO2005030147A2 (en) | 2003-09-26 | 2004-09-27 | Methods of using ammonia oxidizing bacteria |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007508247A JP2007508247A (ja) | 2007-04-05 |
JP2007508247A5 true JP2007508247A5 (ja) | 2007-11-15 |
Family
ID=34396303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006528295A Pending JP2007508247A (ja) | 2003-09-26 | 2004-09-27 | アンモニア酸化細菌の使用方法 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20070148136A1 (ja) |
EP (1) | EP1667646A4 (ja) |
JP (1) | JP2007508247A (ja) |
AU (1) | AU2004275868A1 (ja) |
BR (1) | BRPI0414813A (ja) |
CA (1) | CA2539974A1 (ja) |
WO (1) | WO2005030147A2 (ja) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030065463A (ko) | 2000-08-11 | 2003-08-06 | 데이비드 알. 휘트록 | 질소 산화물 및 질소 산화물 전구체의 생산을 증가시키기위한 암모니아 산화 박테리아를 포함하는 조성물 및 이를이용하는 방법 |
US7591987B1 (en) * | 2003-11-14 | 2009-09-22 | Babcock-Hitachi Kabushiki Kaisha | Method and apparatus for treating ammonia-containing gas |
AU2006249323B2 (en) | 2005-05-27 | 2012-08-30 | The University Of North Carolina At Chapel Hill | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
FI122718B (fi) * | 2007-09-07 | 2012-06-15 | Aalto Korkeakoulusaeaetioe | Rasvan tuottaminen alkoholista |
BR112012003792B1 (pt) | 2009-08-21 | 2020-05-19 | Novan Inc | composição tópica, e, uso da composição tópica |
CN102695528B (zh) | 2009-08-21 | 2016-07-13 | 诺万公司 | 创伤敷料、其使用方法及其形成方法 |
US8591876B2 (en) | 2010-12-15 | 2013-11-26 | Novan, Inc. | Methods of decreasing sebum production in the skin |
US10940169B2 (en) | 2015-11-30 | 2021-03-09 | Joseph E. Kovarik | Method for reducing the likelihood of developing cancer in an individual human being |
US11951139B2 (en) | 2015-11-30 | 2024-04-09 | Seed Health, Inc. | Method and system for reducing the likelihood of osteoporosis |
US11998479B2 (en) | 2011-02-04 | 2024-06-04 | Seed Health, Inc. | Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure |
US11951140B2 (en) | 2011-02-04 | 2024-04-09 | Seed Health, Inc. | Modulation of an individual's gut microbiome to address osteoporosis and bone disease |
US11844720B2 (en) | 2011-02-04 | 2023-12-19 | Seed Health, Inc. | Method and system to reduce the likelihood of dental caries and halitosis |
WO2012118829A2 (en) | 2011-02-28 | 2012-09-07 | Novan, Inc. | Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same |
WO2013139861A1 (en) | 2012-03-20 | 2013-09-26 | Luc Montagnier | Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders |
CN103074278B (zh) * | 2012-12-28 | 2014-04-23 | 浙江至美环境科技有限公司 | 一种氨氧化细菌及其应用 |
US11213552B2 (en) | 2015-11-30 | 2022-01-04 | Joseph E. Kovarik | Method for treating an individual suffering from a chronic infectious disease and cancer |
US11998574B2 (en) | 2013-12-20 | 2024-06-04 | Seed Health, Inc. | Method and system for modulating an individual's skin microbiome |
US11529379B2 (en) | 2013-12-20 | 2022-12-20 | Seed Health, Inc. | Method and system for reducing the likelihood of developing colorectal cancer in an individual human being |
US11026982B2 (en) | 2015-11-30 | 2021-06-08 | Joseph E. Kovarik | Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being |
US11642382B2 (en) | 2013-12-20 | 2023-05-09 | Seed Health, Inc. | Method for treating an individual suffering from bladder cancer |
US11839632B2 (en) | 2013-12-20 | 2023-12-12 | Seed Health, Inc. | Topical application of CRISPR-modified bacteria to treat acne vulgaris |
US11969445B2 (en) | 2013-12-20 | 2024-04-30 | Seed Health, Inc. | Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH |
US11833177B2 (en) | 2013-12-20 | 2023-12-05 | Seed Health, Inc. | Probiotic to enhance an individual's skin microbiome |
US12005085B2 (en) | 2013-12-20 | 2024-06-11 | Seed Health, Inc. | Probiotic method and composition for maintaining a healthy vaginal microbiome |
US11672835B2 (en) | 2013-12-20 | 2023-06-13 | Seed Health, Inc. | Method for treating individuals having cancer and who are receiving cancer immunotherapy |
US11980643B2 (en) | 2013-12-20 | 2024-05-14 | Seed Health, Inc. | Method and system to modify an individual's gut-brain axis to provide neurocognitive protection |
US11826388B2 (en) | 2013-12-20 | 2023-11-28 | Seed Health, Inc. | Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation |
CN111057660B (zh) | 2014-04-15 | 2023-10-31 | Ao生物医学有限责任公司 | 氨氧化型亚硝化单胞菌菌株d23 |
US11225640B2 (en) | 2014-04-15 | 2022-01-18 | Aobiome Llc | Ammonia oxidizing bacteria for treatment of psoriasis |
CN106471129A (zh) * | 2014-05-22 | 2017-03-01 | Ao生物医学有限责任公司 | 用氨氧化细菌制备材料和测试材料的氨氧化细菌的方法 |
CA2949831A1 (en) | 2014-05-22 | 2015-11-26 | Aobiome Llc | Systems and methods for storage and delivery of ammonia oxidizing bacteria |
WO2017004557A1 (en) | 2015-07-02 | 2017-01-05 | Aobiome Llc | Ammonia oxidizing bacteria for treatment of acne |
KR20180022930A (ko) | 2015-07-02 | 2018-03-06 | 에이오바이오미 엘엘씨 | 마이크로바이옴-적합성 화장품 |
EP3487513A1 (en) * | 2016-07-19 | 2019-05-29 | Aobiome LLC | Ammonia oxidizing microorganisms for use and delivery to the gastrointestinal system |
CA3047041A1 (en) * | 2016-12-12 | 2018-06-21 | Aobiome Llc | Ammonia oxidizing microorganisms for the regulation of blood pressure |
US20200171100A1 (en) * | 2017-07-18 | 2020-06-04 | Aobiome Llc | Ammonia oxidizing microorganisms for use and delivery to the visual and auditory systems |
WO2019191449A1 (en) * | 2018-03-30 | 2019-10-03 | Aobiome Llc | Use and delivery of ammonia oxidizing microorganisms for treatment of neurodegenerative disorders |
TW201943428A (zh) | 2018-04-16 | 2019-11-16 | 大陸商上海岸闊醫藥科技有限公司 | 預防或治療腫瘤療法副作用的方法 |
US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
MA53127A (fr) * | 2018-07-11 | 2021-05-19 | Cyclerion Therapeutics Inc | Utilisation de stimulateurs gcs pour le traitement de maladies mitochondriales |
US20240166988A1 (en) * | 2021-03-31 | 2024-05-23 | Jfr Co., Ltd. | Nitrifying bacteria formulation |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5055193A (en) * | 1989-03-09 | 1991-10-08 | Regents Of The University Of Minnesota | Biodegradation of halogenated hydrocarbons utilizing ammonia-oxidizing bacterium |
DE69133584T4 (de) * | 1990-12-05 | 2009-11-19 | The General Hospital Corp., Boston | Vorrichtung zum Behandeln einen Lungengefässverengung und von Asthma |
US5455279A (en) * | 1991-04-19 | 1995-10-03 | The Children's Medical Center Corporation | Regimen method of mediating neuronal damage using nitroglycerine |
AU681999B2 (en) * | 1992-02-07 | 1997-09-18 | Vasogen Ireland Limited | Method of increasing the concentration of nitric oxide in blood |
US5814666A (en) * | 1992-04-13 | 1998-09-29 | The United States As Represented By The Department Of Health And Human Services | Encapsulated and non-encapsulated nitric oxide generators used as antimicrobial agents |
US5910316A (en) * | 1992-08-24 | 1999-06-08 | The United States Of America, As Represented By The Department Of Health And Human Services | Use of nitric oxide-releasing agents to treat impotency |
US5861168A (en) * | 1993-06-11 | 1999-01-19 | The Board Of Trustees Of The Leland Stanford Junior University | Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury |
US6087479A (en) * | 1993-09-17 | 2000-07-11 | Nitromed, Inc. | Localized use of nitric oxide-adducts to prevent internal tissue damage |
US5728705A (en) * | 1993-10-04 | 1998-03-17 | The Trustees Of Columbia University In The City Of New York | Method of inducing vasorelaxation to treat pulmonary hypertension |
GB9320978D0 (en) * | 1993-10-12 | 1993-12-01 | Higenbottam Timohy W | Nitric oxide treatment |
PT726768E (pt) * | 1993-11-02 | 2000-11-30 | Us Health | Utilizacao de compostos libertadores de acido nitrico para o fabrico de um medicamento para proteccao na lesao por isquemia-reperfusao |
US5527825A (en) * | 1994-04-06 | 1996-06-18 | University Of Arkansas | Method of treating schizophrenia, tourette's syndrome, mania, autism, and obsessive compulsive disorder with inhibitors of brain nitric oxide synthase |
US5543430A (en) * | 1994-10-05 | 1996-08-06 | Kaesemeyer; W. H. | Method and formulation of stimulating nitric oxide synthesis |
US5648101A (en) * | 1994-11-14 | 1997-07-15 | Tawashi; Rashad | Drug delivery of nitric oxide |
CA2206119C (en) * | 1994-12-12 | 2008-05-13 | Omeros Medical Systems, Inc. | Irrigation solution and method for inhibition of pain, inflammation and spasm |
US6063407A (en) * | 1995-02-16 | 2000-05-16 | The General Hospital Corporation | Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
US5900433A (en) * | 1995-06-23 | 1999-05-04 | Cormedics Corp. | Vascular treatment method and apparatus |
US5714511A (en) * | 1995-07-31 | 1998-02-03 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs |
US5876603A (en) * | 1995-08-10 | 1999-03-02 | Hitachi Plant Engineering & Construction Co., Ltd. | Method of biologically removing nitrogen and system therefor |
US5849192A (en) * | 1996-02-12 | 1998-12-15 | Basf Corporation | Procedure to recover from nitrification upsets |
US5725492A (en) * | 1996-03-04 | 1998-03-10 | Cormedics Corp | Extracorporeal circulation apparatus and method |
US5910482A (en) * | 1996-03-19 | 1999-06-08 | Board Of Regents, The University Of Texas System | Treatment or prevention of preeclampsia, eclampsia with calcitonin gene related peptide, CGRP analog, progestational agent, nitric oxide source, and cyclooxygenase inhibitor |
US5824669A (en) * | 1996-03-22 | 1998-10-20 | Nitromed, Inc. | Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
US5765548A (en) * | 1996-05-07 | 1998-06-16 | Perry; Bryan J. | Use of nitric oxide in the treatment of exercised induced pulmonary hemorrhaging in equine |
US6057367A (en) * | 1996-08-30 | 2000-05-02 | Duke University | Manipulating nitrosative stress to kill pathologic microbes, pathologic helminths and pathologically proliferating cells or to upregulate nitrosative stress defenses |
US5821112A (en) * | 1996-10-04 | 1998-10-13 | Botto; Willism S. | Biological odor metabolizing compositions and methods of use |
US5807546A (en) * | 1996-10-11 | 1998-09-15 | The United States Of America As Represented By The Secretary Of Agriculture | Livestock mucosal competitive exclusion culture to reduce enteropathogenic bacteria |
US5958427A (en) * | 1996-11-08 | 1999-09-28 | Salzman; Andrew L. | Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications |
US5891472A (en) * | 1996-11-19 | 1999-04-06 | Meri Charmyne Russell | Treatment of equine laminitis |
US20050036996A1 (en) * | 1996-12-24 | 2005-02-17 | Edmond Roussel | Absorbable composition containing propionic bacteria capable of releasing nitric oxide in the human or animal alimentary canal |
US5912019A (en) * | 1997-02-07 | 1999-06-15 | Musc Foundation For Research Development | Compounds for reducing ischemia/reperfusion injury |
US6087087A (en) * | 1997-07-03 | 2000-07-11 | Takashi Yonetani | Treatment of hemoglobin with nitric oxide |
US5895658A (en) * | 1997-09-17 | 1999-04-20 | Fossel; Eric T. | Topical delivery of L-arginine to cause tissue warming |
US5994444A (en) * | 1997-10-16 | 1999-11-30 | Medtronic, Inc. | Polymeric material that releases nitric oxide |
US6056966A (en) * | 1998-05-18 | 2000-05-02 | Baker Norton Pharmaceuticals, Inc. | Method and compositions for treating impotence |
US6080401A (en) * | 1998-11-19 | 2000-06-27 | Reddy; Malireddy S. | Herbal and pharmaceutical drugs enhanced with probiotics |
US6641808B1 (en) * | 1999-09-22 | 2003-11-04 | Lacpro Industries, Llc | Composition for treatment of obesity |
KR20030065463A (ko) * | 2000-08-11 | 2003-08-06 | 데이비드 알. 휘트록 | 질소 산화물 및 질소 산화물 전구체의 생산을 증가시키기위한 암모니아 산화 박테리아를 포함하는 조성물 및 이를이용하는 방법 |
CA2473097A1 (en) * | 2002-01-11 | 2003-07-17 | David R. Whitlock | Compositions including ammonia oxidizing bacteria and methods of using same |
-
2004
- 2004-09-27 US US10/573,513 patent/US20070148136A1/en not_active Abandoned
- 2004-09-27 EP EP04789104A patent/EP1667646A4/en not_active Withdrawn
- 2004-09-27 JP JP2006528295A patent/JP2007508247A/ja active Pending
- 2004-09-27 CA CA002539974A patent/CA2539974A1/en not_active Abandoned
- 2004-09-27 WO PCT/US2004/031690 patent/WO2005030147A2/en active Application Filing
- 2004-09-27 AU AU2004275868A patent/AU2004275868A1/en not_active Abandoned
- 2004-09-27 BR BRPI0414813-4A patent/BRPI0414813A/pt not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2007508247A5 (ja) | ||
Chen et al. | Statistical evidence for the usefulness of Chinese medicine in the treatment of SARS | |
Saravana | Oral pyogenic granuloma: a review of 137 cases | |
Mine et al. | Enamel-smear compromises bonding by mild self-etch adhesives | |
DE60329589D1 (de) | Antikörper gegen den humanen "insulin-like" wachstumsfaktor | |
WO2005063819A3 (en) | Human binding molecule against cd1a | |
WO2005082042A3 (en) | Therapeutic methods employing nitric oxide precursors | |
MY153198A (en) | Inhibitors of protein aggregation | |
EP2623602A3 (en) | Aptamer therapeutics useful in the treatment of complement-related disorders | |
PH12012501687A1 (en) | Acetylcysteine composition and uses therefor | |
WO2006067122A3 (en) | Binding molecules capable of neutralizing west nile virus and uses thereof | |
WO2004046722A3 (de) | Scd40l, papp-a und plazentaler-wachstumsfaktor (pigf) als biochemische markerkombinationen bei kardiovaskulären erkrankungen | |
WO2009106819A3 (en) | Biological materials and uses thereof | |
JP2011511793A5 (ja) | ||
EP2478901A3 (en) | Neurogenic compounds | |
JP2010526090A5 (ja) | ||
WO2006102979A3 (de) | Entzündungsmarker und kombinationen davon als biochemische marker bei kardiovaskulären erkrankungen | |
MX2008001554A (es) | Composiciones que comprenden un donador de no y un ditiolane, y su uso para mejorar la funcion sexual. | |
WO2007002739A3 (en) | Chromium-amino acid complexes in the treatment of diabetes and other diseases | |
ATE424189T1 (de) | Zusammensetzungen mit 5-amino-2- hydroxybenzoesäure und einem reduzierendem zucker | |
WO2006084233A3 (en) | Modulation of endogenous aicar levels for the treatment of diabetes and obesity | |
Klein | Reconnecting, Recommitting, and Renewing. | |
Giannobile | Periodontal surveillance-implications in the promotion of public health | |
김연태 | Association between health status and tooth loss in Korean adults: longitudinal results from the National Health Insurance Service-Health Examinee Cohort, 2002? 2015 | |
POURREZA et al. | Is preemptive kidney transplantation preferred? Updated study |